Page 124 - 2019_08-Haematologica-web

S. Goossens et al.
ity by repressing stemness-inhibiting
microRNAs. Nat Cell Biol. 2009;11(12):
1487-1495.
21. Goossens S, Radaelli E, Blanchet O, et al.
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling. Nat Commun. 2015;6:5794.
22. Goossens S, Janzen V, Bartunkova S, et al. The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization. Blood. 2011;117(21):5620- 5630.
23. Li J, Riedt T, Goossens S, et al. The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signaling. Blood. 2017;129(4):460-472.
24. Higashi Y, Moribe H, Takagi T, et al. Impairment of T cell development in delta EF1 mutant mice. J Exp Med. 1997;185(8): 1467-1479.
25. Omilusik KD, Best JA, Yu BF, et al. Transcriptional repressor ZEB2 promotes terminal differentiation of CD8(+) effector and memory T cell populations during infec- tion. J Exp Med. 2015;212(12):2027-2039.
26. Dominguez CX, Amezquita RA, Guan TX, et al. The transcription factors ZEB2 and T- bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection. J Exp Med. 2015;212(12):2041-2056.
27. Guan T, Dominguez CX, Amezquita RA, et al. ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regu- late CD8(+) T cell fates. J Exp Med. 2018;215(4):1153-1168.
28. Zhang J, Ding L, Holmfeldt L, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481 (7380):157-163.
29. Treanor LM, Zhou S, Janke L, et al. Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymo- cyte progenitors with multipotent potential. J Exp Med. 2014;211(4):701-713.
30. Schmitt TM, de Pooter RF, Gronski MA, Cho SK, Ohashi PS, Zuniga-Pflucker JC. Induction of T cell development and estab- lishment of T cell competence from embry- onic stem cells differentiated in vitro. Nat Immunol. 2004;5(4):410-417.
31. Tatari MN, De Craene B, Soen B, et al. ZEB2-transgene expression in the epidermis compromises the integrity of the epidermal barrier through the repression of different tight junction proteins. Cell Mol Life Sci. 2014;71(18):3599-3609.
32. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol. 2001;230(2):230-242.
33. Goossens S, Radaelli E, Blanchet O, et al. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling. Nat Commun. 2015;6:5794.
34. El Kassar N, Lucas PJ, Klug DB, et al. A dose effect of IL-7 on thymocyte development. Blood. 2004;104(5):1419-1427.
35. Munitic I, Williams JA, Yang Y, et al. Dynamic regulation of IL-7 receptor expres- sion is required for normal thymopoiesis. Blood. 2004;104(13):4165-4172.
36. Goossens S, Vandamme N, Van Vlierberghe
P, Berx G. EMT transcription factors in can- cer development re-evaluated: beyond EMT and MET. Biochim Biophys Acta Rev Cancer. 2017;1868(2):584-591.
37. Miyoshi T, Maruhashi M, Van De Putte T, Kondoh H, Huylebroeck D, Higashi Y. Complementary expression pattern of Zfhx1 genes Sip1 and deltaEF1 in the mouse embryo and their genetic interaction revealed by compound mutants. Dev Dyn. 2006;235(7):1941-1952.
38. Vandewalle C, Comijn J, De Craene B, et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 2005;33(20):6566-6578.
39. Eger A, Aigner K, Sonderegger S, et al. DeltaEF1 is a transcriptional repressor of E- cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene. 2005;24(14): 2375-2385.
40. Postigo AA. Opposing functions of ZEB pro- teins in the regulation of the TGF beta/BMP signaling pathway. EMBO J. 2003;22(10): 2443-2452.
41. Hidaka T, Nakahata S, Hatakeyama K, et al. Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma. Blood. 2008;112(2): 383-393.
42. Trigueros C, Hozumi K, Silva-Santos B, et al. Pre-TCR signaling regulates IL-7 receptor alpha expression promoting thymocyte sur- vival at the transition from the double-nega- tive to double-positive stage. Eur J Immunol. 2003;33(7):1968-1977.
43. Berquam-Vrieze KE, Nannapaneni K, Brett BT, et al. Cell of origin strongly influences genetic selection in a mouse model of T- ALL. Blood, 2011;118(17):4646-4656.
1616
haematologica | 2019; 104(8)